Menu
GeneBe

VRK1

VRK serine/threonine kinase 1

Basic information

Region (hg38): 14:96797303-96954846

Links

ENSG00000100749NCBI:7443OMIM:602168HGNC:12718Uniprot:Q99986AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • pontocerebellar hypoplasia type 1A (Strong), mode of inheritance: AR
  • pontocerebellar hypoplasia type 1A (Strong), mode of inheritance: AR
  • pontocerebellar hypoplasia type 1A (Strong), mode of inheritance: AR
  • pontocerebellar hypoplasia type 1 (Supportive), mode of inheritance: AR
  • microcephaly-complex motor and sensory axonal neuropathy syndrome (Supportive), mode of inheritance: AR
  • pontocerebellar hypoplasia type 1A (Moderate), mode of inheritance: AR
  • pontocerebellar hypoplasia type 1A (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Pontocerebellar hypoplasia type 1A; Neuronopathy, distal hereditary motor, autosomal recessive 10ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingNeurologic19646678; 21937992; 24126608; 30847374; 31090908; 31837156; 35641352; 37257665

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the VRK1 gene.

  • Pontocerebellar hypoplasia type 1A (391 variants)
  • not provided (73 variants)
  • Inborn genetic diseases (53 variants)
  • Congenital pontocerebellar hypoplasia type 1 (26 variants)
  • not specified (20 variants)
  • Neuronopathy, distal hereditary motor, autosomal recessive 10 (5 variants)
  • Distal spinal muscular atrophy (4 variants)
  • Pontoneocerebellar hypoplasia (3 variants)
  • Pontocerebellar hypoplasia type 1B (1 variants)
  • Multiple congenital anomalies (1 variants)
  • Spinal muscular atrophy (1 variants)
  • Hereditary breast ovarian cancer syndrome (1 variants)
  • EMG: neuropathic changes;Microcephaly-complex motor and sensory axonal neuropathy syndrome (1 variants)
  • Juvenile amyotrophic lateral sclerosis (1 variants)
  • Abnormality of the musculature (1 variants)
  • Isolated microphthalmia 2 (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the VRK1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
108
clinvar
2
clinvar
111
missense
1
clinvar
2
clinvar
119
clinvar
122
nonsense
14
clinvar
1
clinvar
15
start loss
0
frameshift
24
clinvar
5
clinvar
3
clinvar
32
inframe indel
2
clinvar
2
splice donor/acceptor (+/-2bp)
1
clinvar
11
clinvar
1
clinvar
13
splice region
7
29
4
40
non coding
10
clinvar
65
clinvar
27
clinvar
102
Total 40 19 136 173 29

Highest pathogenic variant AF is 0.0000461

Variants in VRK1

This is a list of pathogenic ClinVar variants found in the VRK1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
14-96797343-C-T Pontoneocerebellar hypoplasia Likely benign (Jun 14, 2016)369085
14-96797372-C-T Pontoneocerebellar hypoplasia Uncertain significance (Jun 14, 2016)315120
14-96797405-G-C not specified Likely benign (Feb 05, 2018)515189
14-96797429-G-T not specified Likely benign (Jan 16, 2018)514675
14-96797442-C-T Pontocerebellar hypoplasia type 1A Uncertain significance (Apr 27, 2017)888342
14-96797538-C-T Benign (May 26, 2021)1272009
14-96797592-T-C Benign (Jul 03, 2018)1251145
14-96833254-G-A Benign (Jun 19, 2018)675686
14-96833321-A-G Pontocerebellar hypoplasia type 1A Likely benign (Nov 12, 2022)2036933
14-96833460-G-C Likely benign (Sep 16, 2019)507728
14-96833463-A-G VRK1-related disorder Likely benign (Apr 01, 2019)3058377
14-96833476-CT-C Pontocerebellar hypoplasia type 1A Pathogenic (Aug 31, 2023)533538
14-96833478-C-T Pontocerebellar hypoplasia type 1A Uncertain significance (Dec 27, 2021)1044639
14-96833478-CG-TT Congenital pontocerebellar hypoplasia type 1 • Inborn genetic diseases Uncertain significance (Mar 19, 2021)574450
14-96833479-G-A Pontocerebellar hypoplasia type 1A Uncertain significance (Sep 01, 2021)643104
14-96833479-GT-G Pontocerebellar hypoplasia type 1A Pathogenic (Dec 26, 2022)847284
14-96833480-T-G Pontocerebellar hypoplasia type 1A Likely benign (Feb 04, 2022)1106863
14-96833483-A-T Pontocerebellar hypoplasia type 1A Likely benign (Apr 25, 2022)2130552
14-96833492-T-C Pontocerebellar hypoplasia type 1A Likely benign (Jul 12, 2023)2742800
14-96833493-C-T Pontocerebellar hypoplasia type 1A Pathogenic (Feb 21, 2022)2101376
14-96833497-C-T Pontocerebellar hypoplasia type 1A Uncertain significance (Aug 31, 2021)649202
14-96833500-G-A Congenital pontocerebellar hypoplasia type 1 • Inborn genetic diseases • Pontocerebellar hypoplasia type 1A Uncertain significance (Jun 21, 2022)990857
14-96833502-A-T Pontocerebellar hypoplasia type 1A Pathogenic (Jul 10, 2023)2724908
14-96833510-C-T Pontocerebellar hypoplasia type 1A Likely benign (Jul 19, 2023)1648469
14-96833516-A-G not specified • Pontocerebellar hypoplasia type 1A • Isolated microphthalmia 2 Benign (Feb 01, 2024)130731

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
VRK1protein_codingprotein_codingENST00000216639 12134419
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.002110.9971257100361257460.000143
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.171672150.7760.00001132603
Missense in Polyphen3058.0090.51716678
Synonymous0.5706166.90.9110.00000330688
Loss of Function2.94924.80.3630.00000133308

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001490.000149
Ashkenazi Jewish0.001590.00159
East Asian0.0001090.000109
Finnish0.000.00
European (Non-Finnish)0.00009770.0000967
Middle Eastern0.0001090.000109
South Asian0.00003270.0000327
Other0.0003550.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: Serine/threonine kinase involved in Golgi disassembly during the cell cycle: following phosphorylation by PLK3 during mitosis, required to induce Golgi fragmentation. Acts by mediating phosphorylation of downstream target protein. Phosphorylates 'Thr- 18' of p53/TP53 and may thereby prevent the interaction between p53/TP53 and MDM2. Phosphorylates casein and histone H3. Phosphorylates BANF1: disrupts its ability to bind DNA, reduces its binding to LEM domain-containing proteins and causes its relocalization from the nucleus to the cytoplasm. Phosphorylates ATF2 which activates its transcriptional activity. {ECO:0000269|PubMed:10951572, ECO:0000269|PubMed:14645249, ECO:0000269|PubMed:15105425, ECO:0000269|PubMed:16495336, ECO:0000269|PubMed:18617507, ECO:0000269|PubMed:19103756}.;
Disease
DISEASE: Pontocerebellar hypoplasia 1A (PCH1A) [MIM:607596]: A disorder characterized by an abnormally small cerebellum and brainstem, central and peripheral motor dysfunction from birth, gliosis and spinal cord anterior horn cells degeneration resembling infantile spinal muscular atrophy. Additional features include muscle hypotonia, congenital contractures and respiratory insufficiency that is evident at birth. {ECO:0000269|PubMed:19646678}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Clearance of Nuclear Envelope Membranes from Chromatin;Nuclear Envelope Breakdown;Mitotic Prophase;Initiation of Nuclear Envelope Reformation;Nuclear Envelope Reassembly;Mitotic Anaphase;Mitotic Metaphase and Anaphase;M Phase;Cell Cycle;Cell Cycle, Mitotic (Consensus)

Recessive Scores

pRec
0.103

Intolerance Scores

loftool
0.848
rvis_EVS
-0.38
rvis_percentile_EVS
27.69

Haploinsufficiency Scores

pHI
0.720
hipred
Y
hipred_score
0.756
ghis
0.714

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
E
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.966

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Vrk1
Phenotype
endocrine/exocrine gland phenotype; cellular phenotype; normal phenotype; reproductive system phenotype;

Gene ontology

Biological process
protein phosphorylation;mitotic nuclear envelope disassembly;mitotic nuclear envelope reassembly;peptidyl-serine phosphorylation;peptidyl-threonine phosphorylation;histone H3-S10 phosphorylation;protein autophosphorylation;cell division;histone H3-T3 phosphorylation;Golgi disassembly
Cellular component
nucleus;nucleoplasm;nucleolus;cytoplasm;Golgi stack;spindle;cytosol
Molecular function
protein kinase activity;protein serine/threonine kinase activity;protein binding;ATP binding;protein kinase binding;nucleosomal histone binding;histone kinase activity (H3-S10 specific);histone kinase activity (H3-T3 specific)